CABA
Cabaletta Bio, Inc.
Key Financials
Operating Income
$-172241000
↓ 37.6%
Net Income
$-167856000
↓ 44.9%
Total Assets
$165.1M
↓ 10.8%
Cash & Equivalents
$83.0M
↓ 49.4%
Total Liabilities
$53.0M
↑ 62.1%
EPS (Diluted)
$-2.10
↑ 10.3%
Shareholders' Equity
$112.1M
↓ 26.4%
Operating Cash Flow
$-131080000.00
↓ 48.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| SCHEDULE 13G/A | 8/12/2026 | View on SEC |
| SCHEDULE 13G | 8/12/2026 | View on SEC |
| SCHEDULE 13G | 7/31/2026 | View on SEC |
| SCHEDULE 13G | 7/27/2026 | View on SEC |
| SCHEDULE 13G/A | 7/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CABA |
| Company Name | Cabaletta Bio, Inc. |
| CIK | 1759138 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (267) 759-3100 |